Mangalam Drugs & Organics Limited

NSEI:MANGALAM Lagerbericht

Marktkapitalisierung: ₹2.0b

Mangalam Drugs & Organics Management

Management Kriterienprüfungen 3/4

Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.

Wichtige Informationen

Govardhan Dhoot

Geschäftsführender

₹2.0m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts100.0%
Amtszeit als Geschäftsführer28.3yrs
Eigentum des Geschäftsführers6.8%
Durchschnittliche Amtszeit des Managementskeine Daten
Durchschnittliche Amtszeit der Vorstandsmitglieder6.5yrs

Jüngste Management Updates

Recent updates

Mangalam Drugs & Organics Limited's (NSE:MANGALAM) Revenues Are Not Doing Enough For Some Investors

Aug 13
Mangalam Drugs & Organics Limited's (NSE:MANGALAM) Revenues Are Not Doing Enough For Some Investors

A Look At The Intrinsic Value Of Mangalam Drugs & Organics Limited (NSE:MANGALAM)

May 23
A Look At The Intrinsic Value Of Mangalam Drugs & Organics Limited (NSE:MANGALAM)

Little Excitement Around Mangalam Drugs & Organics Limited's (NSE:MANGALAM) Revenues As Shares Take 25% Pounding

Mar 28
Little Excitement Around Mangalam Drugs & Organics Limited's (NSE:MANGALAM) Revenues As Shares Take 25% Pounding

Mangalam Drugs & Organics Limited's (NSE:MANGALAM) Shares Lagging The Industry But So Is The Business

Feb 07
Mangalam Drugs & Organics Limited's (NSE:MANGALAM) Shares Lagging The Industry But So Is The Business

Estimating The Fair Value Of Mangalam Drugs & Organics Limited (NSE:MANGALAM)

Oct 20
Estimating The Fair Value Of Mangalam Drugs & Organics Limited (NSE:MANGALAM)

Is Mangalam Drugs & Organics (NSE:MANGALAM) A Risky Investment?

Mar 29
Is Mangalam Drugs & Organics (NSE:MANGALAM) A Risky Investment?

These 4 Measures Indicate That Mangalam Drugs & Organics (NSE:MANGALAM) Is Using Debt Extensively

May 31
These 4 Measures Indicate That Mangalam Drugs & Organics (NSE:MANGALAM) Is Using Debt Extensively

A Look At The Fair Value Of Mangalam Drugs & Organics Limited (NSE:MANGALAM)

Apr 06
A Look At The Fair Value Of Mangalam Drugs & Organics Limited (NSE:MANGALAM)

We Think Mangalam Drugs & Organics (NSE:MANGALAM) Is Taking Some Risk With Its Debt

Jan 03
We Think Mangalam Drugs & Organics (NSE:MANGALAM) Is Taking Some Risk With Its Debt

Here's Why Mangalam Drugs & Organics (NSE:MANGALAM) Can Manage Its Debt Responsibly

May 23
Here's Why Mangalam Drugs & Organics (NSE:MANGALAM) Can Manage Its Debt Responsibly

Is Mangalam Drugs & Organics (NSE:MANGALAM) A Risky Investment?

Jan 04
Is Mangalam Drugs & Organics (NSE:MANGALAM) A Risky Investment?

Do Its Financials Have Any Role To Play In Driving Mangalam Drugs & Organics Limited's (NSE:MANGALAM) Stock Up Recently?

Nov 12
Do Its Financials Have Any Role To Play In Driving Mangalam Drugs & Organics Limited's (NSE:MANGALAM) Stock Up Recently?

A Look At The Intrinsic Value Of Mangalam Drugs & Organics Limited (NSE:MANGALAM)

Sep 20
A Look At The Intrinsic Value Of Mangalam Drugs & Organics Limited (NSE:MANGALAM)

Does Mangalam Drugs & Organics's (NSE:MANGALAM) Statutory Profit Adequately Reflect Its Underlying Profit?

Aug 05
Does Mangalam Drugs & Organics's (NSE:MANGALAM) Statutory Profit Adequately Reflect Its Underlying Profit?

We Think Mangalam Drugs & Organics (NSE:MANGALAM) Can Stay On Top Of Its Debt

Jul 01
We Think Mangalam Drugs & Organics (NSE:MANGALAM) Can Stay On Top Of Its Debt

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Govardhan Dhoot im Vergleich zu den Einnahmen von Mangalam Drugs & Organics verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Mar 31 2024n/an/a

-₹91m

Dec 31 2023n/an/a

-₹170m

Sep 30 2023n/an/a

-₹171m

Jun 30 2023n/an/a

-₹113m

Mar 31 2023₹2m₹2m

₹13m

Dec 31 2022n/an/a

₹123m

Sep 30 2022n/an/a

₹159m

Jun 30 2022n/an/a

₹182m

Mar 31 2022₹2m₹2m

₹197m

Dec 31 2021n/an/a

₹151m

Sep 30 2021n/an/a

₹175m

Jun 30 2021n/an/a

₹241m

Mar 31 2021₹2mn/a

₹280m

Dec 31 2020n/an/a

₹309m

Sep 30 2020n/an/a

₹261m

Jun 30 2020n/an/a

₹158m

Mar 31 2020₹5m₹2m

₹83m

Dec 31 2019n/an/a

-₹28m

Sep 30 2019n/an/a

-₹89m

Jun 30 2019n/an/a

-₹80m

Mar 31 2019₹2m₹2m

-₹80m

Dec 31 2018n/an/a

₹10m

Sep 30 2018n/an/a

₹114m

Jun 30 2018n/an/a

₹164m

Mar 31 2018₹2m₹2m

₹199m

Vergütung im Vergleich zum Markt: GovardhanDie Gesamtvergütung ($USD23.97K) liegt unter dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt Indian ($USD38.53K).

Entschädigung vs. Einkommen: GovardhanDie Vergütung des Vorstandsvorsitzenden entsprach im vergangenen Jahr der Unternehmensleistung.

Geschäftsführer

Govardhan Dhoot (71 yo)

28.3yrs

Amtszeit

₹2,000,000

Vergütung

Mr. Govardhan Murlidhar Dhoot serves as the Chairman of the Board and Managing Director at Mangalam Drugs & Organics Limited and has been its Executive Director since April 16, 1996.

Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Govardhan Dhoot
Chairman & MD28.3yrs₹2.00m6.81%
₹ 134.6m
Brijmohan Dhoot
Whole-Time Director9.3yrs₹600.00k3.57%
₹ 70.6m
Rukmesh Dhandhania
Independent Director6.8yrs₹36.00kkeine Daten
Nidhi Mundada
Non-Executive Independent Director6.3yrs₹42.00kkeine Daten
Praveen Saxena
Independent Non-Executive Director3.4yrs₹24.00kkeine Daten
Rakesh Milwani
Non-Executive Non- Independent Director2.4yrs₹16.00kkeine Daten

6.5yrs

Durchschnittliche Betriebszugehörigkeit

69yo

Durchschnittliches Alter

Erfahrener Vorstand: MANGALAMDie Vorstandsmitglieder gelten als erfahren (6.3 Jahre durchschnittliche Amtszeit).